SEC Form 4 · accession 0001144204-18-037301
USANA HEALTH SCIENCES INC · USNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gull Global Ltd
10% Owner
Period of report
Jul 2, 2018
Accepted (ET)
Jul 3, 2018 · 7:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 2, 2018 | S | 17,550 | $115.05 | D | 10,518,064 | D | |
| Common StockF2,F3 | Jul 2, 2018 | S | 13,246 | $115.35 | D | 10,504,818 | D | |
| Common StockF2,F4 | Jul 3, 2018 | S | 8,904 | $115.42 | D | 10,495,914 | D | |
| Common StockF2,F5 | Jul 3, 2018 | S | 300 | $115.97 | D | 10,495,614 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Weighted average price. Price range in multiple transactions was $114.30 to $115.25, inclusive.
- F2The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
- F3Weighted average price. Price range in multiple transactions was $115.30 to $115.60, inclusive.
- F4Weighted average price. Price range in multiple transactions was $114.85 to $115.775, inclusive.
- F5Weighted average price. Price range in multiple transactions was $115.90 to $116.00, inclusive.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney